Skip to content

A Comparison Between Lumen-apposing Metal Stent and Double-pigtail Plastic Stents for Treatment of Walled-off Necrosis

Efficacy and Safety of Double-pigtail Plastic Versus Lumen-apposing Metal Stents for Transmural Drainage of Walled-off Necrosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04876235
Enrollment
50
Registered
2021-05-06
Start date
2021-05-01
Completion date
2022-12-31
Last updated
2023-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Walled-off Necrosis

Keywords

endoscopic ultrasound guided drainage, Lumen-apposing metal stent, double-pigtail plastic stents, Walled-off necrosis

Brief summary

Walled-off necrosis (WON) is defined as an encapsulated collection of solid and liquid necrotic material that is usually formed 4 weeks after an episode of acute necrotizing pancreatitis. As the advances in endoscopic techniques and accessories, Endoscopic ultrasound (EUS)-guided transluminal drainage has evolved to become the treatment of choice for symptomatic pancreatic walled-off necrosis (WON). This article aims to compare the efficacy and safety of a double mushroom head metal stent and a double pigtail plastic stent in the treatment of encapsulated necrosis of the pancreas.

Detailed description

According to the revised Atlanta classification, pancreatic fluid collections (PFCs) include acute peripancreatic fluid collections(APFCs) and acute necrotic collections(ANCs), which, over time, turn into pancreatic pseudocysts (PPs) and walled-off pancreatic necrosis (WON). Drainage of these PP and WON is required when they increase in size and become infected or become symptomatic. Traditionally, WON has been managed surgically, however, surgical necrosectomy is associated with substantial morbidity and mortality, particularly when pursued early. In recent years, with the development of minimally invasive techniques, Endoscopic ultrasound (EUS)-guided transluminal drainage has evolved to become the treatment of choice for symptomatic pancreatic walled-off necrosis (WON). Double-pigtail plastic stents(DPPS) is the earliest stent used for WON drainage in ultrasound endoscopy, however, These stents are limited by their small diameter leading to increased risk of stent obstruction. Recently, lumen-apposing metal stents (LAMS) have been increasingly used because of the advantage of better lumen apposition and wider diameter, improving access for endoscopic debridement. However, more adverse events(AEs) such as bleeding have been reported. This article aims to compare the efficacy and safety of DPPS and LAMS in the treatment of Walled-off necrosis

Interventions

PROCEDUREendoscopic ultrasound

All patients were implanted with stents(DPPS or LAMS)under the EUS

In the LAMS group, patients were stented with LAMS

DEVICEdouble-pigtail plastic stents

In the DPPS group, patients were stented with DPPS

Sponsors

First People's Hospital of Hangzhou
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Obtention of a written informed consent * According to Revised Atlanta Classification, abdominal CT/MRI and EUS were diagnosed as WON * The diameter of WON ≥6cm * Patient capable of fill in the quality of life questionnaire * The distance between the EUS-probe and WON was \< 1 cm.

Exclusion criteria

* No written informed consent * pancreatic cystic tumor, pancreatic cancer and other benign and malignant tumors * pancreatic pseudocyst * WON too far from the stomach and duodenum to perform endoscopic drainage * Serious abnormalities in liver and kidney function and coagulation function * Pregnant, parturient or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
clinical success (clinical improvement and resolution of WON)two monthscompare rates of WON resolution in patients with LAMS and DPPS for treatment of walled-off necrosis

Secondary

MeasureTime frameDescription
Adverse Eventstwo monthsNumber of participants with adverse events; type, frequency and intensity of adverse events

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026